RxDoctor Payments Data

Cecily Miller, PA

Physician Assistant · Durham, NCNPI 1205557527

Payments from drug & device makers

$3,659in general payments, 2019–2025

Across 222 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$766
  • Johnson & Johnson$320
  • Supernus Pharmaceuticals, Inc.$307
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$265
  • Ironshore Pharmaceuticals Inc.$227
  • Corium, LLC$227
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$3,647100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,659 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$12,397
Medicare patients
52
Services billed
133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Jornay PmMethylphenidate Hcl11$4,895
Bupropion XlBupropion Hcl70$4,364
Paliperidone ErPaliperidone14$3,752
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl28$3,468
Lamotrigine ErLamotrigine23$3,252
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$2,679
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine104$2,360
Atomoxetine Hcl13$2,272
Aripiprazole14$1,579
Divalproex Sodium ErDivalproex Sodium17$1,335
Quetiapine Fumarate48$1,247
Methylphenidate ErMethylphenidate Hcl13$1,201
RivastigmineRivastigmine Tartrate11$1,193
Duloxetine Hcl32$1,164
Lamotrigine61$1,158

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ironshore Pharmaceuticals Inc.Jornay Pm$227$4,89511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →